Middle market investment bank Harris Williams & Co has advised Crisis Prevention Institute, Inc (CPI), a portfolio company of The Riverside Company (Riverside), on its sale to Brockway Moran and Partners. CPI is a training organisation specialising in the safe management of crisis situations and disruptive behaviour.  The transaction closed on

Odyssey Investment Partners has acquired TNT Crane and Rigging from MML Capital Partners. TNT is the leading mobile crane rental company serving the Texas, Louisiana and Oklahoma region. Financial terms of the transaction have not been disclosed. Headquartered in Houston, Texas, with eight additional branches in the region, TNT provides

Quad Partners, a private equity firm focused exclusively on the education industry, has announced the closing of the firm’s fourth investment fund, Quad Partners IV LP (Quad IV). Quad IV closed at its hard cap of USD200 million with commitments from leading institutional limited partners. Quad Partners was founded in

Rapid7, a provider of security risk intelligence solutions, has secured USD50 million in a series C round from Palo Alto, California-based Technology Crossover Ventures (TCV). The new funding will support Rapid7’s growth strategy in three main areas: hiring critical talent to accelerate product innovation, strategic acquisitions and international expansion.  

Some 291 secondary buyouts worth USD60.4bn have been announced in 2011 to date, surpassing 2010 figure in both volume and value. Transaction type has doubled market share since 2008, and the surge in secondary buyouts is likely to continue apace, with 48% of GPs expecting the number of such transactions

Medtronic and Bain Capital have entered into a definitive agreement under which affiliates of Bain Capital will acquire Physio-Control, a leading provider of emergency medical response technology for use in the intervention and treatment of cardio-respiratory and other medical emergencies. The stock of Physio-Control and related entities will be purchased

Biocartis has completed a EUR 71 million (USD 100 million) Series C equity fund raising backed by existing investors, new investors and industrial collaborators and partners. Investors in the round were Debiopharm Group, Philips, Johnson & Johnson Development Corporation (JJDC), the Wellcome Trust, Korys (investment holding of the Colruyt family),

Forbion Capital Partners has invested in Oxyrane UK Limited, a biopharmaceutical company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than forty rare inherited diseases. In its oversubscribed Series D financing round the company raised USD26.5m. Other investors in the